Biologic and Biosimilar Medicines
key details
| Value | £70,828,856 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Wales |
| Deadline | 18 Oct 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-049b93 |
Awards (19)
This procurement was awarded to 19 suppliers. Values shown are per-award; the notice total is £70,828,856.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | · | · | active |
| Accord-UK Ltd shared | · | · | active |
| Amgen Ltd shared | · | · | active |
| Biogen Idec Limited shared | · | · | active |
| Biosimilar Collaborations Ireland Limited shared | · | · | active |
| Celltrion Healthcare United Kingdom Limited shared | · | · | active |
| Dr Reddy's shared | · | · | active |
| Eli Lilly and Company Limited shared | · | · | active |
| Fresenius Kabi Ltd shared | · | · | active |
| Gedeon Richter (UK) LImited shared | · | · | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Organon Pharmaceuticals UK Ltd shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Teva UK Ltd shared | · | · | active |
| Thornton & Ross Ltd shared | · | · | active |
| Zentiva Pharma UK Limited shared | · | · | active |
description
Biologic and Biosimilar Medicines
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Sept 2024 | Contract notice (F02) | Earlier regulations | 029718-2024 |
| 21 May 2025 | Contract award notice (F03) | Earlier regulations | 024261-2025 |
more from eTenderwales
- Proprietary Drugs · £392,774,896 · 28 Jul 2025
- Influenza Season 2023 · 6 Apr 2023
- Oral Liquids · 9 Jan 2023
- Family Planning Condoms · 27 Jan 2022
- Family Planning Requisites · 26 Jan 2022
- Influenza Vaccine 2022 · 13 Jan 2022
- Provision of Notified Bodies Audit Services · 14 Dec 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.